You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Lightweight Electromagnetic (EM) Shielding Structural Materials
SBC: Conductive Composites Company, L.L.C. Topic: AF121111BLANK
SBIR Phase II 2019 Department of DefenseAir Force -
Optimization of the Ferrous Chloride (FeCl2) and Compliance MX Treatment Chemistries in Managing Chelated Industrial Waste Streams
SBC: CACHE ENVIRONMENTAL LABORATORIES, PC Topic: AF121219With growing regulatory concern over the release of waterborne industrial pollutants, the US Environmental Protection Agency has identified metal finishing as an industrial operation whose pollutant discharge poses a significant threat to public health and the environment. Currently, the US Department of Defense (DoD) weapon system operations rely on metal hydroxide precipitation to treat metal fi ...
SBIR Phase II 2019 Department of DefenseAir Force -
Non-DoD
SBC: Sarcos Group LC Topic: N96T002In this effort, powered upper extremity (two arms and modular, unpowered, application-specific end effectors) of a wearable exoskeleton robot used to augment human performance while performing logistical tasks will be developed, tested and demonstrated. The new exoskeleton, referred to as XO-MAX(UE)-L exoskeleton, will be integrated with the Lower Extremity, XO-MAX(LE)-L exoskeleton, developed und ...
SBIR Phase II 2019 Department of DefenseAir Force -
Targeted Intraceptors for Macular Degeneration
SBC: Iveena Delivery Systems, Inc. Topic: NEIProject Summary Age-related Macular Degeneration (AMD) is the leading cause of blindness in US. It affects over 25% of the people by the age 80. An estimated 25 million people are afflicted with AMD worldwide. Neovascular or “wet” AMD, which affects 10%–15% of AMD patients, is a rapid form of the disease and progresses to blindness if left untreated. Histopathologically, the disease involves ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Noninvasive Functional Cortical Mapping with Innovative tEEG
SBC: CREMEDICAL CORP Topic: 106PROJECT SUMMARY Resective neurosurgery is essential for treating a range of neurologic conditions such as epilepsy and brain tumorsFor some patientswhose lesion is close to cortical language areaspostoperative expressive or receptive language deficit is a major and feared postoperative complicationMuch effort is devoted to identifying the cortical language regionsand relating such localization to ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A multivalent, easy-to-use product to mitigate and treat radiation exposure
SBC: FIBROPLATE INC Topic: NIAIDABSTRACTThe threat of radiological and nuclear accidents or attacks demands for effective radiation medical countermeasuresMCMable to mitigate and treat the effects of exposure to ionizing radiationsHematopoietic acute radiation syndromeHRASand cutaneous radiation syndromeCRSpose severelife threatening risks to exposed individualsCurrently no effective radio mitigatorto be administered after radia ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Accessible And Robust Tools for Glycosaminoglycan Profiling
SBC: ECHELON BIOSCIENCES, INC. Topic: 300Glycosaminoglycans (GAGs) are polysaccharides composed of a repeated disaccharide subunit and known to be important for the maintenance of structure and mechanical properties of the extracellular matrix. More recently, changes in the content, size, and composition of GAGs have been found to play biological roles in disease processes as well. For example, chondroitin sulfate (CS) is the most abunda ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of a Natural Products-Based High Throughput Screen: Identification of Correctors of Cystic Fibrosis Misfolding Mutants
SBC: Synthetic Biodesign, LLC Topic: NCCIHNatural products or their derivatives have accounted for most of our current drugsdemonstrating their unique status asprivilegedmolecules that are well adapted for therapeutic useHowevernatural products have previously been unsuitable for modernhigh throughputHTdrug discovery screening approachesand as suchwere long ago abandoned in drug discovery programs of large pharmaThe substitute has been hi ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Immunoassay for early diagnosis of mucormycosis
SBC: DXDISCOVERY INC Topic: NIAIDMucormycosis is one of the deadliest of the invasive fungal infections. Mucormycosis occurs most often in patients with hematological malignancies undergoing chemotherapy, patients who have received hematopoietic stem cell transplants or patients with diabetes mellitus. Improved diagnosis is the most frequently noted unmet need for management of the mucormycosis patient. Delays in treatment increa ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Developing, Testing and Validating a Wearable Alcohol Biosensor
SBC: Clinitech, LLC Topic: 4501 PROJECT SUMMARY2 This application for a Phase II SBIR award extends the successful completion of Phase I and represents a 3 collaboration between Clinitech, LLC and McLean Hospital/Harvard Medical School to continue the4 development of a wearable biosensor for detecting alcohol in the interstitial fluid of humans. Excessive use of5 alcohol accounts for much of the public health burden related to ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health